1. Home
  2. RVYL vs EVGN Comparison

RVYL vs EVGN Comparison

Compare RVYL & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryvyl Inc.

RVYL

Ryvyl Inc.

HOLD

Current Price

$0.34

Market Cap

9.3M

ML Signal

HOLD

Logo Evogene Ltd

EVGN

Evogene Ltd

HOLD

Current Price

$1.09

Market Cap

10.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVYL
EVGN
Founded
2007
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Professional Services
Agricultural Chemicals
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
10.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RVYL
EVGN
Price
$0.34
$1.09
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$3.50
AVG Volume (30 Days)
7.5M
51.3K
Earning Date
11-14-2025
11-20-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$48,858,000.00
$8,016,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$297.49
$12.35
P/E Ratio
N/A
N/A
Revenue Growth
29.50
7.19
52 Week Low
$0.25
$0.95
52 Week High
$2.33
$2.42

Technical Indicators

Market Signals
Indicator
RVYL
EVGN
Relative Strength Index (RSI) 52.86 41.97
Support Level $0.32 $1.03
Resistance Level $0.37 $1.14
Average True Range (ATR) 0.04 0.07
MACD 0.01 -0.01
Stochastic Oscillator 66.35 31.12

Price Performance

Historical Comparison
RVYL
EVGN

About RVYL Ryvyl Inc.

Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.

Share on Social Networks: